Literature DB >> 10490834

New p73 variants with altered C-terminal structures have varied transcriptional activities.

Y Ueda1, M Hijikata, S Takagi, T Chiba, K Shimotohno.   

Abstract

p73 has been identified as a protein which shares significant homology with the tumor suppressor p53. We found two new types of splicing variant mRNAs for p73 expressed in MCF-7 cells which we named p73gamma and epsilon. Sequence analysis revealed that these mRNAs encode variant p73 proteins bearing distinct carboxy-terminal structures, which are also different from the previously reported variants p73alpha and beta. The mRNAs encoding p73gamma and epsilon as well as alpha and beta were confirmed to be expressed in normal human tissues in varied patterns. All of these splicing variants activated promoter with the p53-binding consensus sequence, but to different degrees. Furthermore, suppressive effects of p73alpha, gamma and epsilon, but not beta, on endogenous p53 activity were observed when transiently expressed in HepG2 and MCF-7 cells. These results suggested that the carboxy-terminal regions of p73 which were altered by alternative splicing affect these transactivation abilities and modulate the functions of p73 molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490834     DOI: 10.1038/sj.onc.1202817

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.

Authors:  Takahito Nakagawa; Masato Takahashi; Toshinori Ozaki; Ken-ichi Watanabe Ki; Satoru Todo; Hiroyuki Mizuguchi; Takao Hayakawa; Akira Nakagawara
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Transcriptional activities of p73 splicing variants are regulated by inter-variant association.

Authors:  Y Ueda; M Hijikata; S Takagi; T Chiba; K Shimotohno
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

3.  Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.

Authors:  Pamela Ghioni; Fabrizio Bolognese; Pascal H G Duijf; Hans Van Bokhoven; Roberto Mantovani; Luisa Guerrini
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

4.  Protein kinase C-dependent phosphorylation regulates the cell cycle-inhibitory function of the p73 carboxy terminus transactivation domain.

Authors:  Ulrika Nyman; Pinelopi Vlachos; Anna Cascante; Ola Hermanson; Boris Zhivotovsky; Bertrand Joseph
Journal:  Mol Cell Biol       Date:  2009-01-21       Impact factor: 4.272

Review 5.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

6.  IkappaB kinase beta promotes cell survival by antagonizing p53 functions through DeltaNp73alpha phosphorylation and stabilization.

Authors:  Rosita Accardi; Mariafrancesca Scalise; Tarik Gheit; Ishraq Hussain; Jiping Yue; Christine Carreira; Agnese Collino; Cesare Indiveri; Lutz Gissmann; Bakary S Sylla; Massimo Tommasino
Journal:  Mol Cell Biol       Date:  2011-04-11       Impact factor: 4.272

7.  p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.

Authors:  Zhen-Hua Xu; Mu-Jun Zhao; Tsai-Ping Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

8.  Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice.

Authors:  Svitlana Kurinna; Sabrina A Stratton; Wen-Wei Tsai; Kadir C Akdemir; Weisong Gu; Pallavi Singh; Triona Goode; Gretchen J Darlington; Michelle Craig Barton
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

9.  PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73.

Authors:  Eliana Munarriz; Daniela Barcaroli; Anastasis Stephanou; Paul A Townsend; Carine Maisse; Alessandro Terrinoni; Michael H Neale; Seamus J Martin; David S Latchman; Richard A Knight; Gerry Melino; Vincenzo De Laurenzi
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).

Authors:  Y Niikura; H Ogi; K Kikuchi; K Kitagawa
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.